Aldeyra Therapeutics, Inc.

NASDAQ:ALDX

6.81 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q4
Revenue 00000.39300000000000000000000008.30224,121,715004.01316.114000-0.265000000000000
Cost of Revenue 000.0620.0610.0660.0650.0640.06700.0650.0640.0630.0610.0680.0670.068000000000000000000000000000000000
Gross Profit 00-0.062-0.0610.326-0.065-0.064-0.0670-0.065-0.064-0.063-0.061-0.068-0.067-0.068000000000008.30224,121,715004.01316.114000-0.265000000000000
Gross Profit Ratio 00000.83100000000000000000000001100110001000000000000
Reseach & Development Expenses 14.6312.44214.976.1844.2986.9626.96311.2368.96111.5414.57112.23412.84112.89411.4747.7267.0286.1344.8866.6349.61416.22410.6657.8498.5497.8816.7936.65.5453.5393.8493.3693.4473.382.8353.5113.1122.0761.2491.1361.4041.1960.6640.4440.40.6660.3250.150.096
General & Administrative Expenses 1.9483.6963.0383.211.7992.5893.385.5674.7353.2453.1444.2492.5632.5473.0693.1052.5052.2562.223.0053.2142.8393.1162.9852.5463.0662.3731.8911.5011.4761.4821.7271.2061.3971.4621.4561.2271.2610.9550.9721.0070.7720.9830.8010.8320.50.6610.1410.02
Selling & Marketing Expenses 00-0.0623.147-0.06600000000000000000000000000000000000000000000
SG&A 1.9483.6962.9763.151.7332.5893.385.5674.7353.2453.1444.2492.5632.5473.0693.1052.5052.2562.223.0053.2142.8393.1162.9852.5463.0662.3731.8911.5011.4761.4821.7271.2061.3971.4621.4561.2271.2610.9550.9721.0070.7720.9830.8010.8320.50.6610.1410.02
Other Expenses 0000000000000000000000000000000000000000000.5681.760.096-0.002-0.036-0.278-21.479
Operating Expenses 16.57816.13817.9469.3336.0319.5510.34316.80313.69714.78517.71516.48415.40415.44114.54310.8319.5338.3897.1069.63812.82819.06313.78110.83411.09510.9479.1668.4917.0475.0155.3315.0964.6534.7764.2974.9674.3393.3382.2042.1092.4111.9681.6461.2451.2331.1660.9860.2920.116
Operating Income -16.578-16.138-18.008-9.394-6.098-9.55-10.343-16.803-13.697-14.785-17.715-16.484-15.404-15.441-14.543-10.831-11.288-8.389-7.106-9.638-12.896-19.016-13.731-17.431-11.095-10.947-9.166-8.491-7.047-5.015-5.331-5.096-4.653-4.776-4.297-4.967-4.339-3.338-2.204-2.109-2.411-1.968-1.646-1.245-1.233-1.166-0.986-0.292-0.116
Operating Income Ratio 0000-15.5310000000000000000000000-1.023-000-1.27-0.28900016.375000000000000
Total Other Income Expenses Net 0.7691.0251.161.3121.3451.3631.3561.1880.7950.231-0.066-0.305-0.35-0.354-0.394-0.459-2.238-0.484-0.414-0.23-0.3320.3010.4040.4970.4620.1340.1160.0940.0920.0290.0220.0050.0020.001-0.006-0-0.017-0.028-0.028-0.028-0.034-0.0410.5111.64710.52810.475-0.583-3.683-21.626
Income Before Tax -15.809-15.113-16.848-8.082-4.753-8.187-8.987-15.616-12.902-14.553-17.781-16.788-15.755-15.795-14.937-11.29-11.771-8.873-7.52-9.868-13.161-18.715-13.327-16.934-10.633-10.813-9.05-8.397-6.955-4.986-5.309-5.091-4.651-4.775-4.303-4.967-4.356-3.366-2.232-2.137-2.445-2.009-1.1350.4029.2959.309-1.569-3.975-21.742
Income Before Tax Ratio 0000-12.1060000000000000000000000-1.011-000-1.269-0.28900016.438000000000000
Income Tax Expense 00-0-0-3.0891.9021.883-0.6960-0.2310.0660.3050.4130.0590.040.024-0.4790.0050.0720.21-1,309,971.690.0290.005-1.310.5250.1630.1420.1110.1250.0570.0480.0320.0280.0280.0220.0250.011-0.007-0.00300-0-1.590.1130.1140.0140.0150.015-21.467
Net Income -15.809-15.113-16.848-8.082-4.753-8.187-8.987-14.919-12.902-14.322-17.847-17.093-15.755-15.795-14.937-11.29-11.292-8.873-7.52-9.868-13.161-18.715-13.327-15.624-10.633-10.813-9.05-8.397-6.955-4.986-5.309-5.091-4.651-4.775-4.303-4.967-4.356-3.366-2.232-2.137-2.445-2.009-1.1350.4029.2959.309-1.569-3.975-21.742
Net Income Ratio 0000-12.1060000000000000000000000-1.011-000-1.269-0.28900016.438000000000000
EPS -0.27-0.25-0.28-0.14-0.08-0.14-0.15-0.250-0.24-0.31-0.29-0.27-0.27-0.28-0.25-0.25-0.23-0.25-0.34-0.45-0.69-0.49-0.58-0.41-0.52-0.46-0.43-0.36-0.32-0.35-0.37-0.34-0.38-0.41-0.51-0.45-0.35-0.27-0.32-0.37-0.36-0.3-0.00228.392.76-4.99-12.64-69.15
EPS Diluted -0.27-0.25-0.28-0.14-0.08-0.14-0.15-0.250-0.24-0.31-0.29-0.27-0.27-0.28-0.25-0.25-0.23-0.25-0.34-0.45-0.69-0.49-0.58-0.39-0.52-0.46-0.43-0.36-0.32-0.35-0.37-0.34-0.38-0.41-0.51-0.45-0.35-0.27-0.32-0.37-0.36-0.3-0.321.94-9.81-4.99-12.64-69.15
EBITDA -15.274-14.571-16.308-7.523-4.172-7.583-8.396-15.057-12.375-14.071-17.307-16.32-15.28-15.313-14.437-10.739-11.282-8.311-6.962-9.356-12.593-18.662-13.274-16.908-10.547-10.765-9.006-8.358-6.914-4.949-5.272-5.055-4.616-4.739-4.266-4.934-4.32-3.331-2.201-2.107-2.41-1.968-1.6461.232-1.231-1.168-0.986-0.292-21.73
EBITDA Ratio 0000-15.3620000000000000000000000-1.008-000-1.26-0.28600016.302000000000000